BioSpring GMBH is a leader in nucleic acid manufacturing, offering a comprehensive range of services that span from research and development to commercial production. With over 25 years of experience, the company specializes in the manufacturing and analysis of nucleic acid therapeutics and diagnostics, ensuring high-quality outputs through strict compliance with current Good Manufacturing Practices (cGMP). Their facilities are equipped with advanced technologies for nucleic acid synthesis and downstream processing, allowing for flexible and efficient production. BioSpring supports clients at various stages of drug development, from small-scale preclinical manufacturing to large-scale clinical and commercial production, with a focus on delivering reproducible product quality and patient safety.

In addition to manufacturing, BioSpring provides extensive analytical services, leveraging state-of-the-art equipment and methodologies to ensure reliable results. Their analytical capabilities include method development and validation for release, stability, and characterization testing of oligonucleotides, as well as biochemical and pharmacokinetic assay development. The company employs a customized approach to analytical validation, adhering to International Council for Harmonisation (ICH) guidelines, which allows them to meet the specific needs of their clients. With a commitment to innovation and collaboration, BioSpring aims to accelerate the development of therapeutic oligonucleotides, facilitating their transition from laboratory research to clinical application.

Germany

BioSpring GMBH

Europe - West

Biologics

BioSpring GMBH

Company Details